CSL Ltd. (CSLLY)
31.52
+0.02
(+0.05%)
USD |
OTCM |
Oct 08, 16:00
CSL Price : 31.52 for Oct. 8, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 08, 2026 | 31.28 | 31.64 | 31.28 | 31.52 | 86219.00 |
| Oct 07, 2026 | 32.14 | 32.14 | 31.30 | 31.51 | 65057.00 |
| Oct 06, 2026 | 31.26 | 31.30 | 31.08 | 31.17 | 48610.00 |
| Oct 05, 2026 | 30.75 | 30.97 | 30.73 | 30.92 | 52100.00 |
| Oct 02, 2026 | 31.05 | 31.05 | 30.39 | 30.54 | 51439.00 |
| Oct 01, 2026 | 32.14 | 32.14 | 30.82 | 30.94 | 127525.0 |
| Sep 30, 2026 | 31.53 | 32.48 | 31.53 | 31.94 | 54107.00 |
| Sep 29, 2026 | 31.80 | 31.91 | 31.68 | 31.91 | 71208.00 |
| Sep 28, 2026 | 31.79 | 32.05 | 31.11 | 32.00 | 64543.00 |
| Sep 25, 2026 | 31.16 | 31.25 | 30.95 | 31.17 | 109699.0 |
| Sep 24, 2026 | 31.75 | 31.75 | 31.32 | 31.44 | 130017.0 |
| Sep 23, 2026 | 30.50 | 31.92 | 30.50 | 31.30 | 62251.00 |
| Sep 22, 2026 | 32.00 | 32.21 | 32.00 | 32.18 | 42539.00 |
| Sep 21, 2026 | 31.50 | 31.96 | 31.50 | 31.91 | 46031.00 |
| Sep 18, 2026 | 31.08 | 31.12 | 30.86 | 31.10 | 65138.00 |
| Sep 17, 2026 | 31.80 | 31.80 | 31.63 | 31.73 | 99484.00 |
| Sep 16, 2026 | 31.10 | 31.53 | 30.60 | 30.80 | 86580.00 |
| Sep 15, 2026 | 31.54 | 31.95 | 31.00 | 31.66 | 215277.0 |
| Sep 14, 2026 | 30.50 | 30.79 | 30.40 | 30.72 | 86773.00 |
| Sep 11, 2026 | 30.00 | 30.03 | 29.49 | 29.91 | 139723.0 |
| Sep 10, 2026 | 30.40 | 30.98 | 30.10 | 30.16 | 153998.0 |
| Sep 09, 2026 | 31.00 | 31.23 | 30.93 | 31.00 | 72992.00 |
| Sep 08, 2026 | 30.23 | 31.67 | 30.23 | 31.55 | 92280.00 |
| Sep 04, 2026 | 31.95 | 31.95 | 31.38 | 31.61 | 42735.00 |
| Sep 03, 2026 | 31.56 | 32.75 | 31.56 | 31.70 | 102853.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Immutep Ltd. | 3.56 |
| Ceryvyn Therapeutics Ltd. - ADR | 0.026 |
| Propanc Biopharma, Inc. | 0.4801 |
| Mesoblast Ltd. | 14.28 |
| Actinogen Medical Ltd. | 0.06 |
Price Related Metrics
| PS Ratio | 3.866 |
| Price to Free Cash Flow | 27.13 |
| Earnings Yield | -4.30% |
| Market Cap | 60.39B |
| Operating PE Ratio | 15.18 |
| Normalized PE Ratio | 21.22 |